RARE downgraded to market perform from outperform by William Blair
William Blair has cut Ultragenyx Pharma’s rating on RARE to market perform from outperform, according to TradingView News via Benzinga ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.